Document Type : Original Article

Authors

1 Professor of Neurology, Stroke fellowship, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran

2 Assistant Professor of Neurology, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Associated professor of Biostatics, Department of Epidemiology and Biostatics, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran

4 Neurologist, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran

Abstract

INTRODUCTION: Stroke is the second leading cause of death worldwide. Recent studies have shown that the COVID-19 pandemic has been associated with a higher frequency of stroke. This study aimed to investigate the epidemiologic aspects of stroke two years before and during the COVID-19 pandemic in Kerman.
METHOD: This cross-sectional study was conducted in Kerman. The participants included all patients with a confirmed diagnosis of stroke. COVID-19 confirmation was based on a positive PCR test. The data was analyzed with SPSS.V24 software.
RESULTS: In this study, 4152 patients with stroke were evaluated. The frequency of stroke before and during the COVID-19 pandemic was the same. The total number of stroke patients with COVID-19 was 298 (8.16%). The frequency of ischemic stroke patients before the COVID-19 pandemic was 1751 and during the pandemic was 1770. Before and after the pandemic, the mean age of ischemic stroke patients was 67.42±14.14 and 64.49±14.46 respectively, which showed a statistically significant difference (P>0.001). Our findings showed a significant difference between the NIHSS of ischemic stroke before and after the pandemic (P<0.001). The mortality rate of stroke patients was 111 before COVID-19 and 115 patients in the first two years of COVID-19. Except for the mortality rate (P<0.001), there was no significant difference in other demographic variables between ischemic stroke patients with and without COVID-19.
CONCLUSION: The patients with ischemic stroke during the COVID-19 pandemic were younger and had more neurological deficits than the ischemic stroke patients before the pandemic. COVID-19 was associated with higher mortality in patients with ischemic stroke.
 

Keywords

Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke 2022; 17(1): 18-29. https://doi.org/10.1177/17474930211065917
Boursin P, Paternotte S, Dercy B, Sabben C, Maïer B. Semantics, epidemiology and semiology of stroke. Soins 2018; 63(828): 24-7. https://doi.org/10.1016/j.soin.2018.06.008
Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn) 2017; 23(1, Cerebrovascular Disease): 15-39. https://doi.org/10.1212/CON.0000000000000416
Tavanaei R, Yazdani KO, Akhlaghpasand M, Zali A, Oraee-Yazdani S. Changed pattern ‎of hospital admission in stroke during COVID-19 pandemic period in Iran: a retrospective study. Neurol Sci 2021; 42(2): 445-53. https://doi.org/10.1007/s10072-020-05030-z
Zhou Y, Li W, Wang D, Mao L, Jin H, Li Y, et al. Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management. Stroke Vasc Neurol 2020; 5(2): 177-9. https://doi.org/10.1136/svn-2020-000398
Forster R, Myklebust T, Gravningen K, Kvale R. Increased risk of COVID-19-associated death in people under 70 with cardiovascular disease compared to the general population-A nationwide, registry-based study from Norway. Eur Heart J 2021; 42(Supplement_1): ehab724. 3135. https://doi.org/10.1093/eurheartj/ehab724.3135
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 2021; 16(2): 137-49. https://doi.org/10.1177/1747493020972922
Galán JTG. Stroke as a complication and prognostic factor of COVID-19. Neurologia 2020; 35(5): 318-22.https://doi.org/10.1016/j.nrleng.2020.04.013
Lee KW, Yusof Khan AHK, Ching SM, Chia PK, Loh WC, Abdul Rashid AMi, et al. Stroke and novel coronavirus infection in humans: a systematic review and meta-‎analysis. Front Neurol 2020; 11: 579070.https://doi.org/10.3389/fneur.2020.579070
Oxley TJ, Mocco J, Majidi S, et al. Large‐vessel stroke as a presenting feature of Covid‐19 in the young. N Engl J Med 2020; 382: e60. https://doi.org/10.1056/NEJMc2009787
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, ‎et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145‐7.https://doi.org/10.1016/j.thromres.2020.04.013
Kremer S, Lersy F, De Sèze J, Ferré JC, Maamar A, Carsin-Nicol B, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology 2020; 297(2): E242-E51.
Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun 2020; 88: 940-4. https://doi.org/10.1016/j.bbi.2020.06.005
Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol 2021: 1-10. https://doi.org/10.1007/s00415-021-10837-7
Diaz-Arocutipa C, Torres-Valencia J, Saucedo-Chinchay J, Cuevas C. ST-segment elevation in patients with COVID-19: a systematic review. N Engl J Med 2020; 382: 2478‐80. https://doi.org/10.1007/s11239-021-02411-9
Nagraj S, Varrias D, Romero GH, Santos HT, Karamanis D, Sagris D, et al. Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis. Stroke 2022; 53(11): 3410-8. https://doi.org/10.1161/STROKEAHA.122.040233
Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020; 324: 799-801. https://doi.org/10.1001/jama.2020.13372
Saberian P, Seyed-Hossyni SH, Ramezani M, Mirbaha S, Szaji M, Arabi S. Concomitant COVID-19 and acute ischemic stroke in patients transferred by ‎emergency medical service during first wave of pandemic in Tehran, Iran; a cross-sectional study. Front Emerg Med 2022; 6; 22:1-4. https://doi.org/10.18502/fem.v6i2.8718
Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, et al. COVID-19 and ischemic stroke. Eur J Neurol 2021; 28(11): 3826-36.https://doi.org/10.1111/ene.15008
Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G, et al. Risk of stroke in hospitalized SARS‐CoV‐2 infected patients: a multinational study. EBioMedicine 2020; 59: 102939. https://doi.org/10.1161/str.52.suppl_1.P88
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS‐CoV‐2 and stroke in a New York healthcare system. Stroke 2020; 51: 2002‐11. https://doi.org/10.1161/STROKEAHA.120.030335
Vogrig A, Gigli GL, Bnà C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett 2021; 743: 135564.https://doi.org/10.1016/j.neulet.2020.135564
Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ‎ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis 2020; 50: 587-95. https://doi.org/10.1007/s11239-020-02228-y
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke 2020; 15(7): 733-42. https://doi.org/10.1177/1747493020937189
Qureshi A, Baskett WI, Huang W, Shyu D, Myers D, Raju M, et al. Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients. Stroke 2021; 52(3): 905-12. https://doi.org/10.1161/STROKEAHA.120.031786
Zini A, Romoli M, Gentile M, Migliaccio L, Picoco C, Dell’Arciprete O, et al. The ‎stroke mothership model survived during COVID-19 era: an observational single-center ‎study in Emilia-Romagna, Italy. Neurol Sci 2020; 41(12): 3395-9. https://doi.org/10.1007/s10072-020-04754-2
Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. Characteristics and ‎outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID‐19 stroke registry. Stroke 2020; 51: e254‐8.
Cappellari M, Zini A, Sangalli D, Cavallini A, Reggiani M, Sepe FN, et al. Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19. Eur J Neurol 2020; 27(12): 2641-5. https://doi.org/10.1111/ene.14511
Katz JM, Libman RB, Wang JJ, Sanelli P, Filippi CG, Gribko M, et al. Cerebrovascular ‎complications of COVID-19. Stroke 2020; 51: e227-31. https://doi.org/10.1161/STROKEAHA.120.031265
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke 2020; 15(7): 733-42. https://doi.org/10.1177/1747493020937189
Khoo A, McLoughlin B, Cheema S, Weil RS, Lambert C, Manji H, et al. Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry 2020; 91: 1013-4. https://doi.org/10.1136/jnnp-2020-323816
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID‐19: a systematic review and meta‐analysis. Int J Stroke 2021; 16(2): 137‐49. https://doi.org/10.1177/1747493020972922
Ebrahimi HA, Saba M, Sedighi B, Kamali H. Study of the involved vascular territories in patients with ischemic stroke in Kerman, Iran. ARYA Atheroscler 2016; 12(5): 250-3.
Sabayan B, Moghadami M, Assarzadegan F, Komachali SHA, Poorsaadat L, Babaeepour Z, et al. COVID-19 respiratory illness and subsequent cerebrovascular events, the initial Iranian experience. J Stroke Cerebrovasc Dis 2021; 30(1): 105454. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105454
Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 2020; 91(8): 889-91. https://doi.org/10.1136/jnnp-2020-323586
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, et al. Risk of ischemic stroke ‎in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA ‎Neurol 2020; 77(11): 1366-72.https://doi.org/10.1001/jamaneurol.2020.2730
Rodriguez F, Solomon N, de Lemos JA, Das SR, Morrow DA, Bradley SM, et al. Racial ‎and ethnic differences in presentation and outcomes for patients hospitalized with COVID-19: findings from the American heart association’s COVID-19 cardiovascular disease registry. Circulation 2021; 143(24): 2332-42. https://doi.org/10.1161/CIRCULATIONAHA.120.052278